Cargando…
Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation
BACKGROUND: IgA nephropathy (IgAN) is the most common primary glomerular disease and the leading cause of the end-stage renal disease in the world. The pathogenesis of IgAN has not been well elucidated, and yet treatment is limited. High-throughput microarray has been applied for elucidating molecul...
Autores principales: | Xia, Ming, Liu, Di, Liu, Haiyang, Peng, Liang, Yang, Danyi, Tang, Chengyuan, Chen, Guochun, Liu, Yu, Liu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273898/ https://www.ncbi.nlm.nih.gov/pubmed/35836957 http://dx.doi.org/10.3389/fmed.2022.881322 |
Ejemplares similares
-
Based on Network Pharmacology Tools to Investigate the Mechanism of Tripterygium wilfordii Against IgA Nephropathy
por: Xia, Ming, et al.
Publicado: (2021) -
Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study
por: Li, Yan, et al.
Publicado: (2022) -
Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of Tripterygium wilfordii (Lév.) Hutch Against IgA Nephropathy
por: Zhao, Juanyong, et al.
Publicado: (2023) -
Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022) -
SUMO1 Promotes Mesangial Cell Proliferation Through Inhibiting Autophagy in a Cell Model of IgA Nephropathy
por: Tan, Xia, et al.
Publicado: (2022)